BioMimetic Shifts Focus To Ortho Following Dental Combo Product Approval

BioMimetic Pharmaceuticals plans to initiate U.S. clinical studies for repairing bone fractures with device-biologic combination products in the first half of 2006

More from Archive

More from Medtech Insight